114 filings
DEFA14A
RNA
Avidity Biosciences Inc
15 May 24
Additional proxy soliciting materials
9:10am
8-K
RNA
Avidity Biosciences Inc
15 May 24
Departure of Directors or Certain Officers
9:09am
S-3ASR
RNA
Avidity Biosciences Inc
9 May 24
Automatic shelf registration
4:22pm
10-Q
2024 Q1
RNA
Avidity Biosciences Inc
Quarterly report
9 May 24
4:13pm
8-K
RNA
Avidity Biosciences Inc
9 May 24
Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
4:07pm
ARS
pw2sliac2b046kehh1f
26 Apr 24
Annual report to shareholders
4:21pm
DEFA14A
5i44vg8205g
26 Apr 24
Additional proxy soliciting materials
4:17pm
S-3ASR
egdfc8 lo7v1
2 Apr 24
Automatic shelf registration
4:15pm
D
qbu32kb4bm0bpfa3
19 Mar 24
$400.21 mm in equity / options / securities to be acquired, sold $400.21 mm, 45 investors
4:47pm
8-K
h2rzeqsj27da8tdk 0fg
4 Mar 24
Regulation FD Disclosure
7:07am
S-8
esq 7s6shh580ep
29 Feb 24
Registration of securities for employees
4:19pm
8-K
zlnk3t81co7zklkfivb
29 Feb 24
Avidity Biosciences Announces Oversubscribed $400 Million Private Placement
4:06pm
S-3ASR
ao2w7rj9
28 Feb 24
Automatic shelf registration
5:32pm
8-K
bplmmzr
28 Feb 24
Avidity Biosciences Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Highlights
4:08pm
8-K
3mbqa67crr8uc55l
5 Jan 24
Departure of Directors or Certain Officers
8:36am
8-K
vgk7j721ccq
14 Dec 23
Other Events
4:14pm
8-K
vgm159tt6rx2sbx06zo
12 Dec 23
Amendments to Articles of Incorporation or Bylaws
8:22pm
8-K
42o8p1u
28 Nov 23
Entry into a Material Definitive Agreement
6:31am